Filing Details
- Accession Number:
- 0001209191-15-052410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-11 18:17:13
- Reporting Period:
- 2015-06-10
- Filing Date:
- 2015-06-11
- Accepted Time:
- 2015-06-11 18:17:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1605325 | J Melanie Herman | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | Interim Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-10 | 1,500 | $11.91 | 4,486 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-06-10 | 875 | $21.92 | 5,361 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-06-10 | 1,750 | $68.48 | 7,111 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-10 | 4,125 | $93.50 | 2,986 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-10 | 1,500 | $0.00 | 1,500 | $11.91 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-10 | 875 | $0.00 | 875 | $21.92 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2015-06-10 | 1,750 | $0.00 | 1,750 | $68.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 875 | 2022-01-03 | No | 4 | M | Direct | |
| 1,312 | 2023-02-15 | No | 4 | M | Direct | |
| 4,250 | 2024-04-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.50 to $93.515, inclusive. The reporting person undertakes to provide, upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 01/03/2012.
- Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 02/15/2013.
- Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 04/01/2014.
Billionaire Hedge Funds
